13F HOLDINGS REPORT
Cormorant Asset Management, LP
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0001583977-23-000005
Total Value
$1.71B
Positions
49
Other Managers
1
Confidential Omitted
No
Holdings (49)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 8,142,100 | $464.1M | 27.07% |
| 2 | BRIDGEBIO PHARMA INC | BBIO | 4,662,530 | $123.0M | 7.17% |
| 3 | AMBRX BIOPHARMA INC | 02290A102 | 9,923,689 | $114.1M | 6.66% |
| 4 | ARCELLX INC | ACLX | 2,150,000 | $77.1M | 4.50% |
| 5 | APELLIS PHARMACEUTICALS INC | APLS | 2,000,000 | $76.1M | 4.44% |
| 6 | CYMABAY THERAPEUTICS INC | 23257D103 | 3,850,000 | $57.4M | 3.35% |
| 7 | OLEMA PHARMACEUTICALS INC | OLMA | 4,504,764 | $55.6M | 3.25% |
| 8 | STRUCTURE THERAPEUTICS INC | GPCR | 1,056,373 | $53.3M | 3.11% |
| 9 | BIOMEA FUSION INC | BMEA | 3,570,872 | $49.1M | 2.87% |
| 10 | IMMUNOVANT INC | IMVT | 1,225,000 | $47.0M | 2.74% |
| 11 | TARSUS PHARMACEUTICALS INC | TARS | 2,621,422 | $46.6M | 2.72% |
| 12 | CABALETTA BIO INC | CABA | 2,879,424 | $43.8M | 2.56% |
| 13 | VAXCYTE INC | PCVX | 665,000 | $33.9M | 1.98% |
| 14 | CRINETICS PHARMACEUTICALS IN | CRNX | 1,101,904 | $32.8M | 1.91% |
| 15 | IMMUNEERING CORP | IMRX | 4,204,364 | $32.3M | 1.88% |
| 16 | PHARVARIS N V | PHVS | 1,361,460 | $28.4M | 1.66% |
| 17 | RAYZEBIO INC | 75525N107 | 1,182,263 | $26.2M | 1.53% |
| 18 | EYEPOINT PHARMACEUTICALS INC | EYPT | 3,200,000 | $25.6M | 1.49% |
| 19 | KARUNA THERAPEUTICS INC | 48576A100 | 140,000 | $23.7M | 1.38% |
| 20 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 1,900,000 | $21.8M | 1.27% |
| 21 | ERASCA INC | ERAS | 10,813,246 | $21.3M | 1.24% |
| 22 | AEROVATE THERAPEUTICS INC | 008064107 | 1,561,696 | $21.2M | 1.24% |
| 23 | MARINUS PHARMACEUTICALS INC | 56854Q200 | 2,625,000 | $21.1M | 1.23% |
| 24 | RHYTHM PHARMACEUTICALS INC | RYTM | 850,000 | $19.5M | 1.14% |
| 25 | EDGEWISE THERAPEUTICS INC | EWTX | 2,946,887 | $16.9M | 0.98% |
| 26 | ENLIVEN THERAPEUTICS INC | ELVN | 1,216,712 | $16.6M | 0.97% |
| 27 | PRAXIS PRECISION MEDICINES I | PRAX | 9,500,000 | $16.2M | 0.95% |
| 28 | IDEAYA BIOSCIENCES INC | IDYA | 600,000 | $16.2M | 0.94% |
| 29 | INSMED INC | INSM | 575,000 | $14.5M | 0.85% |
| 30 | ZENTALIS PHARMACEUTICALS INC | ZNTL | 700,000 | $14.0M | 0.82% |
| 31 | AXONICS INC | 05465P101 | 250,000 | $14.0M | 0.82% |
| 32 | LONGBOARD PHARMACEUTICALS IN | 54300N103 | 2,353,141 | $13.1M | 0.76% |
| 33 | AVIDITY BIOSCIENCES INC | 05370A108 | 1,762,115 | $11.2M | 0.66% |
| 34 | DISC MEDICINE INC | IRON | 225,000 | $10.6M | 0.62% |
| 35 | COGENT BIOSCIENCES INC | COGT | 1,000,000 | $9.8M | 0.57% |
| 36 | ROCKET PHARMACEUTICALS INC | RCKTW | 450,000 | $9.2M | 0.54% |
| 37 | GH RESEARCH PLC | GHRS | 593,043 | $6.0M | 0.35% |
| 38 | RAPT THERAPEUTICS INC | 75382E109 | 325,000 | $5.4M | 0.32% |
| 39 | VERVE THERAPEUTICS INC | 92539P101 | 350,000 | $4.6M | 0.27% |
| 40 | STOKE THERAPEUTICS INC | STOK | 1,087,807 | $4.3M | 0.25% |
| 41 | CENTESSA PHARMACEUTICALS PLC | CNTA | 561,600 | $3.6M | 0.21% |
| 42 | VIGIL NEUROSCIENCE INC | 92673K108 | 616,786 | $3.3M | 0.19% |
| 43 | ALX ONCOLOGY HLDGS INC | ALXO | 612,079 | $2.9M | 0.17% |
| 44 | BIOHAVEN LTD | BHVN | 81,963 | $2.1M | 0.12% |
| 45 | BIOATLA INC | BCAB | 1,181,115 | $2.0M | 0.12% |
| 46 | NEUMORA THERAPEUTICS INC. | NMRA | 92,293 | $1.3M | 0.08% |
| 47 | AUTOLUS THERAPEUTICS PLC | AUTL | 392,167 | $913,749 | 0.05% |
| 48 | HARPOON THERAPEUTICS INC | 41358P205 | 54,060 | $217,862 | 0.01% |
| 49 | ORCHARD THERAPEUTICS PLC | 68570P200 | 25,664 | $198,383 | 0.01% |